Scientists at the University of New York have developed an artificial-intellectual test capable of predicting the risk of a relapse into breast cancer faster and less costly than existing genetic research, as described in the journal Nature Communications.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Scientists at the University of New York have developed an artificial-intellectual test capable of predicting the risk of a relapse into breast cancer faster and less costly than existing genetic research, as described in the journal Nature Communications.